World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Fassio E, Barreyro FJ, Pérez MS, Dávila D, Landeira G, Gualano G, Ruffillo G. Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations? World J Hepatol 2022; 14(2): 354-371 [PMID: 35317172 DOI: 10.4254/wjh.v14.i2.354]
URL:	https://www.wjgnet.com/1007-9327/full/v14/i2/354.htm

(229) (256) (0) (0) (0) (29) (11664) (12)

Number	Citing Articles
1	Minghao Chen, Wei Wang, Dawei Jie, Lijun Gu. Interplay between exosomes and the PD-1/PD-L1 axis in hepatocellular carcinoma: Implications for immune escape and immunotherapy. Critical Reviews in Oncology/Hematology 2026; 222 doi: 10.1016/j.critrevonc.2026.105234
2	Masayuki Ueno, Haruhiko Takeda, Atsushi Takai, Hiroshi Seno. Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives. World Journal of Gastroenterology 2022; 28(27): 3410-3421 doi: 10.3748/wjg.v28.i27.3410 Abstract(1896) \| Core Tip(1100) \| Full Article(HTML)(5585) \| Full Article (PDF)-606K(665) \| Full Article (Word)-133K(108) \| Audio-706K(23) \| Peer-Review Report-225K(260) \| Answering Reviewers-113K(248) \| Times Cited (26) \| Total Visits (12648) \| Open
3	Kuan-Hung Wan, Hsin-Ming Wang, Chih-Chi Wang, Yueh-Wei Liu, Wei-Feng Li, Yi-Hao Yen, Yuan-Hung Kuo, Chao-Hung Hung, Tsung-Hui Hu, Wei-Chen Tai, Mu-Jung Tsai, Ming-Chao Tsai. Prognostic Significance of Histologic Steatotic Liver Disease in Curatively Resected Non-B, Non-C Hepatocellular Carcinoma. Cancers 2026; 18(9) doi: 10.3390/cancers18091447
4	Coosje A.M. Verhagen, Jochem M. Grossouw, Joep de Bruijne, Danny van der Helm, Jeffrey P.B.M. Braak, Judith de Vos-Geelen, Heinz-Josef Klümpen, Frederik J.H. Hoogwater, Simeon J.S. Ruiter, Maarten W. Nijkamp, Kevin Wiese, Matthijs Kramer, Merve Rousian, Pam E. van der Meeren, Wojciech G. Polak, Caroline M. den Hoed, Otto M. van Delden, Bas Groot Koerkamp, Roeland F. de Wilde, R. Bart Takkenberg, Mark C. Burgmans, Minneke J. Coenraad. Real-world hepatocellular carcinoma management and guideline adherence in the Netherlands: A 5-year multicentre prospective cohort study. Annals of Hepatology 2027; 32(1) doi: 10.1016/j.aohep.2026.102250
5	Muhammad Imran Ahmad, Muhammad Umair Khan, Sudha Kodali, Akshay Shetty, S Michelle Bell, David Victor. Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges. Journal of Hepatocellular Carcinoma 2022; doi: 10.2147/JHC.S344559
6	Carmen Colaci, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, Luigi Boccuto, Carmela Colica, Francesco Luzza, Emidio Scarpellini, Nahum Mendez-Sanchez, Ludovico Abenavoli. Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease. Hepatoma Research 2024; 10 doi: 10.20517/2394-5079.2023.134
7	Sanghwa Kim, Yeonhwa Song, Su-Yeon Lee, Kang mo Kim, Haeng Ran Seo. GRP78/BiP as a novel midbody component induces mitotic exit failure via PLK1 stabilization in hepatocellular carcinoma. BMB Reports 2026; 59(8) doi: 10.5483/BMBRep.2025-0233
8	Cristiane Valle Tovo, Angelo Zambam de Mattos, Gabriela Perdomo Coral, Giovana D P Sartori, Livia Villela Nogueira, Gustavo Tovo Both, Cristiane A Villela-Nogueira, Angelo A de Mattos. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis. World Journal of Gastroenterology 2023; 29(2): 343-356 doi: 10.3748/wjg.v29.i2.343 Abstract(1273) \| Core Tip(1205) \| Full Article(HTML)(5644) \| Full Article (PDF)-3376K(630) \| Full Article (Word)-377K(166) \| Audio-946K(16) \| Peer-Review Report-183K(214) \| Answering Reviewers-82K(209) \| Times Cited (29) \| Total Visits (12308) \| Open
9	Takashi Saito, Mutsumi Tsuchishima, Mikihiro Tsutsumi, Joseph George. Molecular pathogenesis of metabolic dysfunction‐associated steatotic liver disease, steatohepatitis, hepatic fibrosis and liver cirrhosis. Journal of Cellular and Molecular Medicine 2024; 28(12) doi: 10.1111/jcmm.18491
10	天明赵. Analysis of Risk Factors for Hyperlipidemia after Liver Transplantation: A Single-Center Retrospective Study. Advances in Clinical Medicine 2026; 16(04) doi: 10.12677/acm.2026.1641290
11	Xia Niu, Yanan Meng, Yucheng Wang, Guiling Li. Established new compound IMB16-4 self-emulsifying drug delivery systems for increasing oral bioavailability and enhancing anti-hepatic fibrosis effect. Biomedicine & Pharmacotherapy 2022; 154 doi: 10.1016/j.biopha.2022.113657
12	Chun-Ye Zhang, Ming Yang. Artificial intelligence in liver disease: Current status and future direction. Artificial Intelligence in Cancer 2026; 7(1): 119655 doi: 10.35713/aic.119655 Abstract(69) \| Core Tip(73) \| Full Article(HTML)(290) \| Full Article (PDF)-1052K(53) \| Full Article with Cover (PDF)-1371K(28) \| Full Article (XML)-153K(26) \| Audio-705K(0) \| Peer-Review Report-238K(38) \| Answering Reviewers-100K(40) \| Times Cited (0) \| Total Visits (1721) \| Open

Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.